|MURRAY HILL, N.J., Feb 19, 2003 (BUSINESS WIRE) -- C. R. Bard, Inc. (NYSE-BCR)
announced today that its wholly-owned subsidiary, Bard Access Systems, Inc.,
along with Dr. Thierry Pourchez, has filed suit in the United States District
Court for the Southern District of New York on February 11, 2003 against Diatek,
Inc. and Arrow International, Inc.
The suit alleges that Arrow and Diatek's Cannon-Cath split-tip dialysis
catheters infringe U.S. patent number 6,001,079, a patent owned by Dr. Pourchez
and licensed exclusively to Bard Access Systems. Bard Access Systems acquired
the exclusive license to the patent in October 2002. William H. Longfield,
chairman and chief executive officer commented, "Bard is initiating this lawsuit
in order to protect the valuable benefits of Dr. Pourchez's invention. The
company will continue to vigorously defend its intellectual property."
C.R. Bard, Inc., headquartered in Murray Hill, New Jersey, is a leading
multinational developer, manufacturer and marketer of healthcare products in the
fields of vascular, urology, oncology and surgical specialty products. Bard
markets its line of dialysis catheter products through its wholly-owned
subsidiary, Bard Access Systems, Inc.
This press release contains forward-looking statements, the accuracy of which is
necessarily subject to risks and uncertainties. Please refer to our September
30, 2002 Form 10-Q for a statement with regard to forward-looking statements,
including disclosure of additional factors that could cause actual results to
differ materially from those expressed or implied.
CONTACT: C. R. Bard, Inc.
Investor Relations: Todd C. Schermerhorn
Vice President and Treasurer
Holly P. Glass
Government and Public Affairs
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
Copyright (C) 2003 Business Wire. All rights reserved.